The time to exhaustion (tlim) at the respiratory compensation point (RCP) and whether a physiological steady state is observed at this workload remains unknown. Thus, this study analyzed tlim at the power output eliciting the RCP (tlim at RCP), the oxygen uptake (VO2) response to this effort, and the influence of endurance fitness. Sixty male recreational cyclists (peak oxygen uptake [VO2peak] 40–60 mL∙kg∙min−1) performed an incremental test to determine the RCP, VO2peak, and maximal aerobic power (MAP). They also performed constant-load tests to determine the tlim at RCP and tlim at MAP. Participants were divided based on their VO2peak into a low-performance group (LP, n = 30) and a high-performance group (HP, n = 30). The tlim at RCP averaged 20 min 32 s ± 5 min 42 s, with a high between-subject variability (coefficient of variation 28%) but with no differences between groups (p = 0.788, effect size = 0.06). No consistent relationships were found between the tlim at RCP and the different fitness markers analyzed (RCP, power output (PO) at RCP, VO2peak, MAP, or tlim at MAP; all p > 0.05). VO2 remained steady overall during the tlim test, although a VO2 slow component (i.e., an increase in VO2 >200 mL·min−1 from the third min to the end of the tests) was present in 33% and 40% of the participants in HP and LP, respectively. In summary, the PO at RCP could be maintained for about 20 min. However, there was a high between-subject variability in both the tlim and in the VO2 response to this effort that seemed to be independent of fitness level, which raises concerns on the suitability of this test for fitness assessment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.